David J. Marguglio, Senior VP of Corporate Devel at Adamis Pharmaceuticals Corp (ADMP), sold 700 shares at $9.00 ($6K) on 2016-06-02, disclosed to the SEC on 2016-06-06.
Scheduled sale ($6k) by Senior VP of Corporate Devel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ADMP | SELL | 2020-11-24 | $14K | — | Filing → |
| ADMP | SELL | 2020-11-20 | $3K | — | Filing → |
| ADMP | SELL | 2020-10-01 | $16K | — | Filing → |